A 32-year prospective study of change in body weight and incident dementia: The Honolulu-Asia Aging Study

Archives of Neurology

Volumn 62, Issue 1, 2005, Pages 55-60

  Stewart, Robert ^a   Masaki, Kamal ^b   Xue, Qian Li ^c   Peila, Rita ^d   Petrovitch, Helen ^b   White, Lon R ^b   Launer, Lenore J ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASIAN AMERICAN; BODY WEIGHT; CARDIOVASCULAR RISK; CASE FINDING; COGNITION; CONTROLLED STUDY; DEMENTIA; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES; VASCULAR DISEASE;

AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; BODY MASS INDEX; COGNITION DISORDERS; COHORT STUDIES; DEMENTIA; EDUCATIONAL STATUS; GERIATRIC ASSESSMENT; HUMANS; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; WEIGHT LOSS;

EID: 12144268588     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.1.55     Document Type: Article

References (36)

1. White H, Pieper C, Schmader K, Fillenbaum G. Weight change in Alzheimer's disease. J Am Geriatr Soc. 1996;44:265-272.
2. Cronin-Stubbs D, Beckett LA, Scherr PA, et al. Weight loss in people with Alzheimer's disease: a prospective population based analysis. BMJ. 1997;314: 178-179.
3. White H, Pieper C, Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998;46:1223-1227.
4. Poehlman ET, Dvorak RV. Energy expenditure, energy intake, and weight loss in Alzheimer disease. Am J Clin Nutr. 2000;71(suppl):650S-655S.
5. Gillette-Guyonnet S, Nourhashémi F, Andrieu S, et al. Weight loss in Alzheimer's disease. Am J Clin Nutr. 2000;71(suppl):S637-S642.
6. Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thai LJ. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology. 1996;46:1585-1591.
7. Vanhanen M, Kivipelto M, Koivisto K, et al. APOE-epsilon4 is associated with weight loss in women with AD. Neurology. 2001;56:655-659.
8. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc. 1996; 44:1147-1152.
9. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues J-F, Barberger-Gateau P. Body mass index and incidence of dementia: the PAQUID study. Neurology. 2003;60:117-119.
10. Symė SL, Marmot MG, Kagan A, Kato H, Rhoads G. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: introduction. Am J Epidemiol. 1975;102:477-480.
11. White L, Petrovitch H, Ross GW, et al. Prevalence of dementia in older Japanese-American men in Hawaii. JAMA 1996;276:955-960.
12. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21:49-55.
13. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6:45-58.
14. Lee J-H, Olichney JM, Hansen LA, Hofsetter CR, Thal LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol. 2000;57:1474-1479.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
16. McKhann G, Drachmen D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
17. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42: 473-480.
18. Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558-560.
19. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;3:385-401.
20. Takeshita J, Masaki K, Ahmed I, et al. Are depressive symptoms a risk factor for mortality in elderly Japanese-American men? the Honolulu-Asia Aging Study. Am J Psychiatry. 2002;159:1127-1132.
21. Havlik RJ, Izmirlian G, Petrovitch H, et al. APOE-epsilon4 predicts incident AD in Japanese-American men: the Honolulu-Asia Aging Study. Neurology. 2000; 54:1526-1529.
22. SAS Institute Inc. SAS Technical Report P-229. Cary, NC: SAS Institute Inc; 1992: 287.
23. Reynolds MW, Fredman L, Langenberg P, Magaziner J. Weight, weight change, and mortality in a random sample of older community-dwelling women. J Am Geriatr Soc. 1999;47:1409-1414.
24. Stevens J, Juhaeri, Cai J. Changes in body mass index prior to baseline among participants who are ill or who die during the early years of follow-up. Am J Epidemiol. 2001;153:946-953.
25. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ. 1996;312:608-611.
26. Launer LJ, Wind AW, Deeg DJH. Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol. 1994;139:803-812.
27. Shatenstein B, Kergoat M-J, Nadon S. Anthropometric changes over 5 years in elderly Canadians by age, gender, and cognitive status. J Gerontol. 2001;56A: M483-M488.
28. Sparks DL, DeKosky ST, Markesbery WR. Alzheimer's disease: aminergic-cholinergic alterations in hypothalamus. Arch Neurol. 1988;45:994-999.
29. Swaab DF, Grundke-lqbal I, Iqbal K, Kremer HPH, Ravid R, van de Ness JAP. Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease. Brain Res. 1992;590:239-249.
30. van de Nes JA, Kamphorst W, Ravid R, Swaab DF. The distribution of Alz-50 immunoreactivity in the hypothalamus and adjoining areas of Alzheimer's disease patients. Brain. 1993;116:103-115.
31. Goudsmit E, Hofman MA, Fliers E, Swaab DF. The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease. Neurobiol Aging. 1990;11:529-536.
32. Jefferson MF, Burlinson S, Burns A, et al. Clinical features of dementia associated with apolipoprotein epsilon4: discrimination with a neural network genetic algorithm. Int J Geriatr Psychiatry. 2001;16:77-81.
33. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003;163:1524-1528.
34. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003;27:260-268.
35. Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol. 1991;134:403-412.
36. Rivière S, Gillette-Guyonnet S, Nourhashemi F, Vellas B. Nutrition and Alzheimer's disease. Nutr Rev. 1999;57:363-367.